Immunoglobulin (Ig)M+IgD+ B cells are generally assumed to represent antigen-inexperienced, naive B cells expressing variable (V) region genes without somatic mutations. We report here that human IgM+IgD+ peripheral blood (PB) B cells expressing the CD27 cell surface antigen carry mutated V genes, in contrast to CD27-negative IgM+IgD+ B cells. IgM+IgD+CD27+ B cells resemble class-switched and IgM-only memory cells in terms of cell phenotype, and comprise ∼15% of PB B lymphocytes in healthy adults. Moreover, a very small population (<1% of PB B cells) of highly mutated IgD-only B cells was detected, which likely represent the PB counterpart of IgD-only tonsillar germinal center and plasma cells. Overall, the B cell pool in the PB of adults consists of ∼40% mutated memory B cells and 60% unmutated, naive IgD+CD27− B cells (including CD5+ B cells). In the somatically mutated B cells, VH region genes carry a two- to threefold higher load of somatic mutation than rearranged Vκ genes. This might be due to an intrinsically lower mutation rate in κ light chain genes compared with heavy chain genes and/or result from κ light chain gene rearrangements in GC B cells. A common feature of the somatically mutated B cell subsets is the expression of the CD27 cell surface antigen which therefore may represent a general marker for memory B cells in humans.
In T cell–dependent immune responses, naive B cells are recruited into the germinal centers (GC)1 of peripheral lymphoid organs after antigen activation. Within these structures, antibody mutants are generated through the process of somatic hypermutation. Eventually, high affinity B cells are selected either into the plasma cell or the memory B cell pool (1). In the mouse, memory B cells have mostly switched from the initial expression of IgM to that of other Ig classes. Therefore, it came as a surprise that in humans, substantial numbers of IgM-expressing memory B cells seem to occur along with the “classical” class-switched memory B cells (2, 3). We identified a population of somatically mutated IgM-bearing B cells in the peripheral blood (PB), namely IgM+IgD− (IgM-only) cells (4), that phenotypically, and presumably also functionally (5), resemble class-switched cells. In the PB, IgM-only and class-switched cells each comprise 10–15% of all B lymphocytes. IgM-only cells also occur at high numbers in the various lymphoid organs (see reference 4), notably in the splenic marginal zone (6, 7).
Despite the extensive characterization of human B cell subsets at the level of rearranged V genes in recent years, no concordant picture arose as to whether somatically mutated B cells also accumulate in the IgD-expressing compartment. Several studies on tonsillar IgM+IgD+ B cells (8–10) as well as IgD-expressing PB B cells (11, 12) have indicated that somatically mutated IgD memory B cells occur, if at all, at a low frequency. This implies that in humans, as in the mouse, IgD represents a marker for naive B cells. However, the recent work of Paramithiotis and Cooper (13) challenges this view: based on the findings of (a) mutated μ-transcripts in cDNA libraries generated from mature bone marrow B cells and (b) a high number of mature IgM+IgD+ cells in the marrow, they concluded that IgD-bearing memory B cells home to this primary lymphoid organ. In the study of Paramithiotis and Cooper, IgD-expressing B cells were not selectively analyzed, and because somatically mutated B cells express higher levels of Ig mRNA than naive B cells (4), it remains uncertain which fraction of the mutated μ-transcripts was indeed derived from the presumed IgM+IgD+ memory B cells in the bone marrow, and not from IgM-only memory cells or (contaminating) IgM plasma cells.
A special case represents tonsillar IgD+IgM− GC B cells that have deleted the cμ gene and harbor an exceptionally high load of somatic mutations (12). These cells probably differentiate into somatically mutated IgD-only plasma cells homing to the tonsillar subepithelium (14), but descendents of those cells have not been observed in the PB (12).
Maurer et al. (15) and Agematsu et al. (16) recently described two subsets of IgD+ B cells in human tonsils and PB, respectively, that can be distinguished by the expression of the CD27 cell surface antigen, a member of the TNF receptor family. This antigen is expressed on essentially all IgD−, i.e., class-switched and IgM-only, PB B cells. In vitro, IgD+CD27+ but not IgD+CD27− cells respond to activation stimuli in the same way as IgD−CD27+ B cells. Here we characterize this newly described IgD+ CD27+ B cell subset with respect to both the level of V gene mutation and cell phenotype, and compare those cells with class-switched and IgM-only memory B cells as well as with IgD+CD27− cells.
Materials And Methods
Cell Separation and Flow Cytometry.
Buffy coats of healthy adult donors were obtained from the blood bank of the Institut für Transfusionsmedizin of the Cologne University Hospital. PBMC were isolated by Ficoll-Isopaque density centrifugation, and CD19+ B cells were enriched to >98% by magnetic cell separation using the MiniMACS® system (Miltenyi Biotec, Bergisch Gladbach, Germany) as described (11). For the analysis of cell surface antigens, the B cell–enriched cell suspension was incubated with biotinylated goat anti–human IgD (GaH-IgD; Southern Biotechnology Associates, Inc., Birmingham, AL), with FITC- or PE-conjugated anti-CD27 (PharMingen, San Diego, CA) and with either anti-CD23–FITC, anti-CD5–FITC (both from Becton Dickinson, Mountain View, CA), or GaH-IgM–PE (Sigma, München, Germany) for 10 min on ice. After washing with PBS/ 0.5% BSA, GaH-IgD was developed with Streptavidin-CyChrome (PharMingen). The cell suspensions were analyzed on a FACScan® (Becton Dickinson).
For the isolation of single IgD+CD27+ and IgD+CD27− B cells from the PB of three healthy donors, the B cell–enriched cell suspensions were preincubated for 5 min with 1 mg/ml Beriglobin (Behringwerke AG, Marburg, Germany), a human Ig fraction, followed by an incubation with FITC (isomer 1)-conjugated anti-CD27 and biotinylated GaH-IgD for 15 min. After washing and a further 5-min incubation with Beriglobin, the cell suspension was stained with digoxygenated anti–FITC-isomer 1 (a gift of A. Thiel, Deutsches Rheuma-Forschungszentrum, Berlin, Germany). After two washing steps, the cells were incubated on ice with FITC-containing antidigoxigenin liposomes for 30 min under constant agitation (for the manufacturing of liposomes, see reference 17). After three washing steps, single IgD+CD27+ and IgD+CD27− B cells were sorted on a FACS® 440 (Becton Dickinson) directly into PCR tubes containing 20 μl Expand High Fidelity PCR buffer (Boehringer Mannheim, Mannheim, Germany) and 20 ng 5S rRNA. Likewise, single IgM-only as well as IgD-only PB B cells were isolated from donor 3 after staining the CD19+-enriched cell suspension against IgD and IgM as described above.
For the isolation of single κ-expressing IgG+&IgA+ PB B lymphocytes, PBMC were isolated from 50 ml PB of a healthy volunteer (donor 4). PBMC were incubated with anti-κ (Becton Dickinson), and, after washing, goat anti–mouse (GaM)-κ microbeads (Miltenyi Biotec GmbH) as described (18). The cell suspension was stained with biotinylated GaH-IgD and both GaH-IgG–FITC (Southern Biotechnology Associates, Inc.) and GaH-IgA–FITC (Dako, Hamburg, Germany), followed, after washing, by an incubation with Streptavidin-CyChrome. Individual IgG+&IgA+ B cells were isolated as described above.
Single cells in PCR buffer (see above) were incubated with 0.5 mg/ml proteinase K for 1 h at 50°C. The enzyme was inactivated by denaturation at 95°C (10 min). For the first round of amplification, a primer mix consisting of six VH and four Vκ family–specific primers, which recognize sequences in framework region (FR) I of the members of the VH1–6 and the Vκ1–4 gene families, and both a 3′JH and a 3′Jκ primer mix were used (18–20). The first round of amplification was carried out in the same reaction tube in a 50-μl volume containing Expand High Fidelity buffer (Boehringer Mannheim), 2.5 mM MgCl2, 100 μM dATP, dGTP, dTTP, and dCTP, 50 nM of each primer, and 2.5 U Expand High Fidelity polymerase (Boehringer Mannheim). The amplification program consisted of 35 cycles of 60 s at 95°C, 30 s at 59°C, and 60 s at 72°C, followed by a final incubation step at 72°C for 5 min. Enzyme was added after the first denaturation step. For the second round of amplification, the same Vκ family–specific primers and the VH primers for the three largest VH families (VH 1, 3, and 4) were used together with a 5′JH or 5′Jκ primer mix (18, 20). The second round of amplification was performed in separate reactions for each of the three VH and Vκ primers using 1 μl of the first round reaction mixture in a 50-μl volume containing 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl2, 100 μM dATP, dGTP, dTTP, and dCTP, 125 nM of each primer, and 0.7 U Taq DNA polymerase. The amplification conditions were as described above, except that 45 cycles were applied and the annealing temperature raised to 61°C. For the amplification of rearranged VH genes from IgD-only cells, VH family–specific primers were used that hybridize to sequences in the leader-peptide region of the members of the VH1, 3, and 4 gene families (21). The respective PCR reaction mixtures and cycling conditions were as described above. PCR products were purified by gel electrophoresis. An aliquot of the isolated DNA was sequenced directly using the Ready Reaction DyeDeoxyTerminator or BigDye cycle sequencing kit (Perkin-Elmer Applied Biosystems, Weiterstadt, Germany) and an ABI377 sequencer (Perkin-Elmer Applied Biosystems). Nucleotide sequences were analyzed using DNASIS software (Pharmacia GmbH, Freiburg, Germany) and the IMGT database (http://www.genetik.uni-koeln.de/dnaplot/). Some of the sequenced PCR products turned out to represent either non-Ig sequences or double sequences of two rearrangements using the same V gene family. These sequences are not further considered. Some PCR products were not sequenced.
IgD+CD27+ PB B Lymphocytes Phenotypically Resemble Class-switched and IgM-only Memory Cells.
Functional studies performed on isolated IgD−CD27+, IgD+CD27+, and IgD+CD27− PB B cells revealed that IgD+CD27+ B cells respond in a similar way to activating stimuli as IgD− B cells (16). To examine whether IgD+CD27+ cells share phenotypic similarities with “classical” class-switched and IgM-only memory cells, we stained this subset for cell surface markers which are differentially expressed on memory B cells on the one hand and naive B cells on the other, namely CD23 and CD5 (see reference 4). B cell–enriched fractions from several donors were stained for IgD, CD27, and the respective antibodies against CD23 and CD5 and analyzed on a FACScan® (Fig. 1). Like class-switched and IgM-only cells, IgD+CD27+ B cells were predominantly CD23− and CD5−. The IgD+CD27− fraction, on the other hand, contained both CD23+ and CD5+ cells (Fig. 1). Staining for IgM expression revealed that the majority of IgD+CD27+ cells—in contrast to IgD+CD27− cells— express high levels of surface IgM (Fig. 1). In this respect, IgD+CD27+ cells resemble IgM-only B cells (4). To confirm the observation of Agematsu et al. that IgD− B lymphocytes express CD27 (16), IgG+, IgA+, and IgM-only B cells were selectively analyzed for CD27 expression. As expected, cells of those subsets were CD27+ (data not shown).
To determine the percentages of the IgD−CD27+, IgD+CD27+, and IgD+CD27− subsets among PB B lymphocytes, B cell–enriched fractions from the PB of eight healthy adults were stained for IgD and CD27 and analyzed flow-cytometrically (not shown). The PB of the donors showed considerable variation in the frequencies of the PB B cell subsets, with 29–65% IgD+CD27−, 6.5–22% IgD+CD27+, and 13–43% IgD−CD27+ B cells. In accord with previous results (16), the B cell pool in the PB comprises on average 60% IgD+CD27−, 15% IgD+CD27+, and 25% IgD−CD27+ B cells. The latter population can be further subdivided in on average 15% IgG+&IgA+ and 10% IgM-only cells.
IgD-expressing PB B Cells Can Be Subdivided into Somatically Mutated IgM+IgD+CD27+ B Cells and Unmutated IgM+IgD+CD27− B Cells.
IgD+CD27+ and IgD+CD27− PB B cells were analyzed for the level of somatic mutation in their rearranged VH genes. After enrichment of CD19+ B cells derived from the PB of three healthy adults by magnetic cell separation, the corresponding cell suspensions were stained for IgD and CD27 (using FITC-conjugated liposomes; see Materials and Methods), and single IgD+CD27+ and IgD+CD27− cells were isolated flow-cytometrically. The use of FITC-conjugated liposomes, which stain 100–1,000 times brighter than FITC or PE, was necessary to achieve a good separation of the CD27+ and CD27− populations on the FACS® 440. Sorting gates set for the isolation of single cells of the respective subsets are indicated in Fig. 2. While IgD+CD27+ cells were isolated from all three donors, IgD+CD27− cells were sorted only from donors 1 and 2. Since the vast majority of both IgD+CD27+ and IgD+CD27− B cells coexpress IgM (see Fig. 1), these populations are designated below as IgM+IgD+CD27+ and IgM+IgD+CD27− B cells, respectively.
Rearranged VH genes were amplified by PCR from the genomic DNA of the cells using a seminested approach. Negative controls consisted of reaction mixtures without cells and were always negative. From the 3 donors, a total of 156 cells were analyzed. From 69 cells a potentially functional rearrangement, and from 6 cells only a nonfunctional rearrangement, were obtained. 12 cells gave rise to 2 V gene rearrangements; in 9 cases a nonfunctional VHDHJH joint was amplified in addition to a potentially functional rearrangement; and in the remaining cases, 2 potentially functional joints were obtained. The amplification of two potentially functional rearrangements from one sample could either be due to sorting of two cells into one reaction tube or could indeed reflect the presence of two functional VH gene rearrangements in a B cell, as has been described for cases of B cell chronic lymphocytic leukemia (22). However, it is also possible that in those cells one of the potentially functional rearrangements was in reality not functional. All sequences represented unique VHDHJH joints (not shown). The results of the sequence analysis are listed in Table 1.
Whereas all but 1 of the 32 rearranged VH genes amplified from the IgM+IgD+CD27− cells were unmutated, 63 of 67 VH genes analyzed from the IgM+IgD+CD27+ population showed somatic mutations (1–30-bp differences compared with the most homologous germ-line genes; Table 1). In 11 of the rearrangements of the IgM+ IgD+CD27+ fraction, deletions/insertions of variable sizes were identified in addition to point mutations (Table 1). This is in accord with recent findings of a considerable frequency of deletions and/or insertions in B cells undergoing somatic mutation (20, 23). The average somatic mutation frequencies of the IgM+IgD+CD27+ B cells (considering only nucleotide exchange mutations) were determined to be 3.7% for donor 1, 5.0% for donor 2, and 5.9% for donor 3 (see Table 3). These results demonstrate that in addition to IgM-only B cells, IgM+IgD+CD27+ cells represent a further population of IgM-bearing B cells in the PB that express somatically mutated V genes. Furthermore, this analysis shows that IgM+IgD+ B cells which carry unmutated V genes are CD27−.
Since replacement mutations are usually counterselected within the FRs of antibody V region genes to preserve the structure of the V domain, antigen-selected B cells show on average a replacement/silent (R/S) mutation ratio between 1.0 and 1.5, i.e., considerably smaller than the value expected assuming random mutagenesis (∼3.0; reference 24). For the IgM+IgD+CD27+ B cells, an R/S value of the mutations within the FRs of 1.5 was determined (not shown), which is in the same range as that typical for class-switched and IgM-only memory B cells (24).
A Minute Fraction of PB B Cells Consists of IgM −IgD+CD27+ Cells Expressing Highly Mutated VH Region Genes.
In most samples of B cell–enriched cell suspensions stained for IgM and IgD, an IgD+IgM− population could be recognized that comprised usually <1% of PB B lymphocytes. These cells were found to be CD27+ (Fig. 3). To determine whether such cells harbor somatically mutated V genes, single IgM−IgD+ cells were flow-cytometrically isolated from the B cell–enriched cell suspension of donor 3 stained against IgD and IgM (not shown). IgD-only cells comprised <0.5% of PB B lymphocytes in this case. Rearranged V genes were amplified from the genomic DNA using VH leader primers in a seminested PCR strategy as described above. 34 cells were analyzed. From 13 cells, 1 VH gene rearrangement each was amplified. The sequences of all amplificates were unique (not shown). Four rearrangements were unmutated. The remaining nine VHDHJH joints carried a high load of somatic mutations ranging from 15 to 59 bp differences to their respective VH germline genes (Table 2). The high load of somatic mutation within the rearranged V region genes of IgD-only B cells might also explain why the PCR efficiency for these cells was relatively low (13 of 34 cells positive): mutations at the primer binding sites may have often resulted in failure of successful amplification. Six of these sequences were potentially functional, one represented an out-of-frame rearrangement, and in two instances the functionality of the original rearrangement before the accumulation of mutations was uncertain (Table 2). Three of the mutated rearrangements showed deletions and/or insertions.
The unmutated sequences likely stemmed from contaminating IgM+IgD+CD27− B cells, which represent a much larger cellular compartment than IgD-only cells. The mutated sequences show an exceptionally high mutational load (average 15.2%) which has previously been described only for V regions expressed by IgD-only GC B cells (∼12% mutation; reference 12) and IgD-only tonsillar plasma cells (14). Therefore, it appears that the IgM−IgD+ B cells analyzed here represent the PB descendents of IgD-only GC B cells. Since IgM−IgD+CD27+ cells were included in the sorter gate set for the isolation of IgD+CD27+ cells, it is possible that some of the (highly mutated) sequences in the analysis of those cells (Table 1) were indeed derived from IgD-only B cells. The low average R/S value for mutations within the FRs of the six potentially functional VH region genes of the IgD-only cells (1.4) indicates selection of these cells for antigen receptor expression.
The Level of Somatic Mutation in VH Regions Expressed by IgM+IgD+CD27+ B Cells Is in the Same Range as That of IgM-only B Cells.
The average VH gene mutation frequency of IgM+IgD+CD27+ B cells was determined to be ∼5%. In our previous work, we focused on rearranged Vκ genes to determine mutation frequencies of PB B cell subsets (4, 11, 18). To reliably compare the average V gene mutation frequency of the IgM+IgD+CD27+ fraction with that of the other somatically mutated, IgM-expressing subset (IgM-only cells), we isolated single IgM-only B cells from donor 3 and determined the level of somatic mutation in VH regions. 32 IgM-only cells were analyzed. From 16 cells, 1 potentially functional rearrangement per cell was amplified, and from 1 cell, both a nonproductive and a productive VHDHJH joint (not shown). One potentially functional VH gene rearrangement showed a 3-bp deletion in CDRII. All sequences showed unique VHDHJH joints (not shown). All but one of the rearrangements were somatically mutated (5–21-nucleotide differences), yielding an average mutation frequency of 5.8% (Table 3). Thus, the VH gene mutation frequency determined for IgM-only cells is in the same range as that of the IgM+IgD+CD27+ cells analyzed from the same donor (5.9%; Table 3).
In Humans, Vκ Genes Are Considerably Less Mutated than VH Region Genes.
To determine whether the Vκ genes of IgM+IgD+CD27+ and IgM-only B cells also harbor a similar load of somatic mutations, rearranged Vκ genes were amplified from the genomic DNA of IgD+CD27+ B cells in which mutated VH regions had already been identified. From the 3 donors, a total of 44 IgD+CD27+ B cells, from which VH gene rearrangements had been obtained, were analyzed for Vκ rearrangements. From 20 cells, 1 rearrangement was obtained per cell; 3 cells gave rise to 2, 1 cell to 3 VκJκ joints (Table 4). From 12 cells only a potentially functional, from 9 cells 1 or 2 nonfunctional, and from 3 cells both a productive and a nonproductive rearrangement were amplified (Table 4).
All nonproductive Vκ rearrangements were found to be unmutated. This is most likely due to the fact that in λ- (and some κ-) expressing B cells, κ loci harboring nonproductive Vκ rearrangements are usually inactivated by a deletion of both the Cκ gene and the κ-enhancers (25). VκJκ joints are often retained on the chromosome, and such VκJκ joints appear not to be subject to somatic mutation (26, 27). Therefore, it seems reasonable to consider only potentially functional Vκ regions for the determination of the average Vκ gene mutation frequency in IgM+IgD+CD27+ cells.
14 of the 15 cells that carried a potentially functional Vκ rearrangement showed somatic mutations (1–11-bp differences; Table 4) in the respective VκJκ joints. The average mutation frequency was 2.0% (Table 4). The corresponding VH gene mutation frequency of the cells in which a mutated Vκ region could be identified amounts to 6.1% (see Table 4). Thus, IgM+IgD+CD27+ cells show a level of somatic mutation in their Vκ regions that is in the same range as that seen in IgM-only cells (2%; reference 4), and in both populations of B cells, the Vκ regions are considerably less mutated than the VH region genes.
To further confirm that the lower level of somatic mutations in κ versus heavy chain genes is a general feature of human B cells, we also amplified VH and Vκ region genes from single class-switched, κ-expressing B cells of a fourth adult donor. Indeed, the average mutation frequency of 18 VH region genes amounted to 6.1%, whereas the average mutation frequency of 8 Vκ region genes was twofold lower, namely 3.0% (not shown).
IgM+IgD+CD27+ B Cells Presumably Represent a Third Phenotypically Defined Memory B Cell Subset in Humans.
Almost all IgM+IgD+CD27+ B cells analyzed carried somatically mutated V region genes, in contrast to IgM+ IgD+CD27− B lymphocytes (Table 1). IgM+IgD+ CD27+ cells phenotypically resemble both class-switched and IgM-only cells in that they are CD27+, CD23−, and CD5− (Fig. 1; reference 4), and generally appear to be larger than CD27− B cells (15, 16; our unpublished observations). Unlike IgM+IgD+CD27− cells, they express high levels of membrane IgM (Fig. 1), similar to IgM-only cells (4). That IgM+IgD+CD27+ cells may represent memory B cells is further supported by the following observations. (a) Upon stimulation in in vitro assays, both IgD−CD27+ and IgD+CD27+ cells—in contrast to IgD+CD27− cells—are quickly activated and secrete large amounts of Ig (15, 16). This is consistent with one of the key features of memory B cells, as reported for splenic marginal zone and tonsillar subepithelial memory B cells (28, 29). (b) A small fraction of tonsillar GC B cells expresses IgD, and half of those cells carry somatically mutated V region genes (30). These GC B cells might be the precursors of the IgM+IgD+CD27+ PB B cells. A second potential precursor population for the IgM+IgD+CD27+ B cells is represented by a rare type of tonsillar GC which are populated by somatically mutated IgD+CD70+ GC B cells (31; Küppers, R., and C. van Noesel, unpublished observations). IgM+IgD+CD27+ PB B cells are also CD70+ (32; our unpublished observations). (c) CD27-expressing B cells are almost absent from cord blood (16, 33), which is devoid of memory B cells. Although it presently cannot be ruled out that IgM+IgD+CD27+ B lymphocytes are generated in a GC-independent pathway (34), these observations collectively suggest that these cells, besides class-switched and IgM-only cells, represent a third phenotypically defined memory B cell subset in human PB. Regarding the mutated μ-transcripts identified in cDNA libraries generated from mature bone marrow B cells (13), it seems likely that those transcripts were derived from both IgM-only and IgM+IgD+CD27+ memory cells homing to or circulating through the bone marrow.
IgD-only B Cells in the PB Carry Highly Mutated V Region Genes.
We observed a minute fraction of IgD-only B cells in the PB, usually representing <1% of PB B cells (our unpublished observations). They are CD27+ (Fig. 3) and express V region genes with an exceptionally high load of somatic mutation (Table 2), as has been described for IgD-only GC B cells (12) and tonsillar IgD-only plasma cells (14). Based on these similarities, it seems likely that the IgD-only cells in the PB represent the descendents of IgD-only GC B cells. Thus, it appears that IgD-only GC cells can differentiate not only into tonsillar plasma cells, but also into recirculating sIgD+ cells. The fact that these highly mutated cells express surface Ig and that the average R/S mutation value for the FRs of the potentially functional VH region genes amplified from IgD-only cells (1.4) is in the range typical for antigen-selected memory B cells indicates that these cells have been selected within the GC for antigen receptor expression.
In Human Memory B Cells, VH Region Genes Harbor on Average a Two- to Threefold Higher Load of Somatic Mutations than Vκ Region Genes.
In our previous V gene analyses on B cell subsets derived from healthy adults, we repeatedly determined somatic mutation frequencies of ∼2% for IgM-only and 4% for class-switched cells (4, 11, 18). Those values were derived from analyzing rearranged Vκ genes. The average VH gene mutation frequency of ∼5% in IgD+ CD27+ B cells (Tables 1 and 3 made us wonder whether VH regions may in general carry a higher load of somatic mutations than Vκ regions. To clarify this, we sequenced rearranged VH genes from IgM-only cells as well as Vκ regions from IgD+CD27+ cells. Furthermore, from one donor VH and Vκ region genes were amplified from single class-switched B cells. Indeed, within a given cell population, VH regions show a two- to threefold higher average mutation frequency than Vκ regions (Tables 3 and 4. The same conclusion can be drawn from the results of both a V gene analysis of sporadic Burkitt's lymphomas (n = 9; Vκ: 1.8% average mutation frequency, VH: 3.4% ) and a single cell study of rearranged VH as well as Vκ genes expressed by IgM-bearing PB B lymphocytes (36). The present data also demonstrate that IgD+CD27+ B cells show a level of somatic mutation in the same range as that of IgM-only cells (2% for Vκ [Table 4, and reference 4]; ∼5% for VH [Table 3]).
The simplest interpretation of the lower mutation frequency of Vκ than VH genes is that the intrinsic mutation rate is higher in the latter. However, the lower mutation load of Vκ genes could also be due to novel Vκ gene rearrangements in GC B cells (37, 38), which would have gone through fewer rounds of somatic mutation than the corresponding VH gene rearrangements.
The VH gene mutation values discussed above hold true for adults. For μ- and γ-transcripts derived from tonsillar and PB memory B lymphocytes of children, we and others previously reported mutation frequencies of 2 and 4%, respectively (9, 10). What could be the explanation for the discrepancy between the mutation frequencies of memory cells in children and in adults? Perhaps the hypermutation mechanism is not yet fully active in GC B lymphocytes of children. Alternatively, memory B cells may be driven repeatedly into GC reactions where they acquire additional somatic mutations. However, the mutation load does not appear to increase considerably in adults with advancing age (4, 11).
The Peripheral B Cell Pool in Humans.
On the basis of the present data, B cells that express unmutated V genes are IgM+IgD+CD27− and comprise ∼60% of PB B cells. Lipsky and colleagues find a similar fraction (55%) of unmutated or slightly mutated V genes amplified from individual CD19+ PB B lymphocytes (39). IgM+IgD+CD27− B cells can be further distinguished into a large population of CD5− cells and a smaller subset of CD5+ B cells (18). The latter are thought to belong to a separate B cell lineage (for a review, see reference 40) and presumably do not regularly participate in T cell–dependent immune responses (41, 42). They comprise 10–20% of B cells in the adult PB. CD5-negative IgM+IgD+CD27− cells are termed naive B cells as they represent the presumed precursors of GC B cells in T cell–dependent immune responses. These cells make up between 40 and 50% of PB B lymphocytes (Fig. 4).
About 40% of PB B cells represent memory B cells (Fig. 4). There is evidence that such cells occur at similar numbers also in secondary lymphoid organs (summarized in reference 4). The large fraction of memory B cells in humans contrasts with the situation in the mouse, where the frequency of memory B cells (in old, nonintentionally immunized mice) is in the range of 5% of all peripheral B lymphocytes (43). This difference might largely be explained by the longer life span of humans, leading to the accumulation of a much larger fraction of memory B cells. IgD and/ or IgM-expressing memory B cells were described in rodents and chickens already 20 years ago (24, 44–46). However, these cells were not phenotypically or molecularly characterized in detail, and there is no information on the size of this memory compartment in those species. In models of T cell–dependent immune responses in the mouse, memory B cells almost exclusively express isotypes other than IgM and IgD, indicating that the memory B cell pool shows a different composition in mice and in humans. In humans, IgM-bearing memory cells seem to predominate over class-switched memory cells (4; Fig. 4): human memory B cells can be distinguished into (on average) 40% class-switched, 20% IgM-only, and 40% IgM+IgD+CD27+ cells (and probably a small population of IgD-only cells). A common characteristic of these subsets is the expression of the CD27 cell surface antigen, which thus may represent a general marker for memory B cells in humans. CD27-expressing B cells can be activated through interaction with the CD27 ligand, CD70 (47), a molecule belonging to the TNF receptor family which is found on peripheral T cells, and recently it was shown that B cells stimulated via CD27– CD70 interaction acquire a plasma cell phenotype in vitro (48). This finding suggests that memory B cells, activated by antigen in the context of T–B cell interaction, may quickly, as a result of an additional CD27 stimulation, differentiate into Ig-secreting cells. Although in vitro the differentiation of memory B cells into plasma cells can be achieved without CD27 stimulation (29), it is tempting to speculate that in vivo CD27–CD70 interaction represents the key signal to bias memory B cells to the plasma cell differentiation pathway.
Kindler and Zubler note that in vitro–activated IgM-only PB B cells differentiate into plasma cells, but do not change isotype even under conditions that promote switching in a large fraction of IgM+IgD+ B cells (5). This indicates that IgM-only memory B cells are committed to secrete IgM. Such behavior of IgM-only cells may be explained by an internal rearrangement between the 5′ and 3′ ends of the sμ regions, resulting in deletion of this region (49, 50). Thus, further switching to downstream isotypes in IgM-only (and potentially also IgM+IgD+CD27+) B cells may be abolished.
Despite the prevalence of IgM-expressing over “classical” class-switched memory B cells, the role of IgM- expressing memory cells in T cell–dependent immune responses remains elusive. Are IgM-only and IgM+IgD+ CD27+ cells as a rule generated in the course of a T cell– dependent immune response from a fraction of GC B cells that do not undergo class switching? Or are they generated specifically against particular pathogens? Do IgM+IgD+ CD27+ memory cells upon antigen stimulation secrete IgD in addition to IgM? Pentameric IgM enables efficient cross-linking of antigen and permits a strong activation of the complement system. These features are advantageous in the defense against bacteria. In this regard, it is interesting to note that the splenic marginal zone, the entry port of blood-borne antigens, is mainly populated by IgM-only memory B cells (6, 7). Perhaps these cells have been generated to quickly respond to bacteria that invade the bloodstream.
This work was supported by the Deutsche Forschungsgemeinschaft through SFB243 and SFB502.
Abbreviations used in this paper
We are most grateful to Michaela Fahrig for excellent technical assistance and Alexander Scheffold for providing FITC-conjugated liposomes. We thank Christoph Göttlinger for help with the FACS®, Julia Jesdinsky for sequencing work, and Andreas Thiel for discussions.
Address correspondence to Ralf Küppers, University of Cologne, University Hospital, LFI E4 R706, Joseph-Stelzmannstr. 9, 50931 Cologne, Germany. Phone: 49-221-478-4490; Fax: 49-221-478-6383; E-mail: email@example.com